Articles
Latest Articles
BACK TO SCHOOL 2020
COVID-19 RESOURCE CENTER
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
search
Gathering data...
Previous
article
Back
to Feed
Next
article
Share
Text Size
A
A
A
Print
HS-tk vector bearing the gene for thymidine kinase: Began Phase I/II trial in 15 patients, with direct injection of the vector into tumor, followed by treatment
By
WIR Staff
| Mar 13, 1995 | 8:00 AM GMT
Genetic Therapy Inc.
(GTII),
Read the full
49
word article
How to gain access
Purchasing Options
Log In
Continue reading with a
two-week free trial.
Try free trial
Previous
article
Back
to Feed
Next
article
JavaScript is necessary to work with this application.